Lancet editor reverses himself: MMR and adverse events

Teresa Binstock
Researcher in Developmental & Behavioral Neuroanatomy
February 15, 2010



Circa 2010, the MMR autism controversy has not abated despite The Lancet's retraction of a peer-reviewed case-studies paper the journal's editor Richard Horton has described as scientifically sound (1-2). Indeed, the primary reason for the retraction appears to have been the researchers' having considered the possibility that the MMR vaccination may have initiated some children's regression into autism with gastrointestinal pathology (3).

There are two primary issues: Are measles mumps rubella (MMR) vaccinations etiologically significant in some cases of regressive autism? Are MMR vaccinations etiologically significant in the gastrointestinal pathology of some autistic children?

Mainstream media would have us believe the answer to each question is no: The MMR is neither a causal factor nor a co-factor in some cases of autism and has no relevance to intestinal pathologies in subgroups of children with autism or one of the other autism-spectrum disorders. However, findings in other peer-reviewed studies are consistent with the idea that MMR vaccinations induce adverse sequelae in some children.

Part 1
: Richard Horton, The Lancet editor, affirms sound science in Wakefield et al 1998

In 2006, The Observer, a major London news magazine, printed an article by Sally Beck, wherein The Lancet editor Richard Horton said the scientific findings in Wakefield et al 1998 were valid.

'
Horton was quick to confirm that the science in the paper, which looked at whether 12 autistic children also suffered bowel disease, was good.

'
He reiterated his statement in his evidence to the GMC, "There was no question in my mind that subject to external peer review and editor debate, we should publish this work," he said. "The description of what seemed to be a new syndrome and its relations to possible environmental triggers was original and would certainly have interested our readers." ' (2)

Furthermore, the 1998, Wakefield et al finding of gastrointestinal pathology in a subgroup of autistic children has been confirmed numerously (4-11; see also 12-13); and in 2010, the American Academy of Pediatrics journal "Pediatrics" published two major reviews focusing upon evaluation and treatment of gastrointestinal pathologies in autistic children (14-15; see also 16-17).

Part 2: Richard Horton, The Lancet editor, reverses himself

In 2010, an article in the New York Times (18) made clear that Richard Horton is reversing his 2006 statements. He denounces the Wakefield et al 1998 study and -- perhaps most importantly -- admits that the 1998 article's vaccine/autism speculation became The Lancet's error which led to retraction. Consider statements from NYTimes blogger Tara Parker Pope:

'
The study was retracted after concerns about ethical breaches by one of the study authors. In addition, 10 of the 13 co-authors have disavowed the study’s conclusions. ”We fully retract this paper from the published record,” The Lancet editors said in a statement.

'
But the damage has been done. The paper has fueled fears about the risks of childhood vaccinations and autism, particularly the M.M.R. vaccine, despite numerous studies showing no link.

'
This week, National Public Radio’s “On the Media” explored the role the media played in inflaming fears about vaccines and autism, asking how “bad science” made its way into The Lancet and the “collective psyche.”...' (18)

Irony abounds. A study whose findings have been numerously replicated has been retracted. Thus the 1998 article's primary conclusion - the description of a finding of gastrointestinal pathology in a subgroup of autistic children - is not going away. Perhaps the recantation by 10 of the 13 co-authors and the retraction by The Lancet was less about the intestinal pathology findings and more about the researchers having dared consider the possibility that, for some children, their regression into autism and their gastrointestinal pathology may have been initiated by the MMR vaccination.

Not suprisingly, Timothy Buie, M.D., and colleagues have been able to understand and express the core concern:

"
In 1998, Wakefield et al... reported an association between ileocolitis and developmental regression in 12 children and coined the term “autistic enterocolitis.” From the same uncontrolled study they reported NLH [nodular lymphoid hyperplasia] of the ileum and colon as an abnormal finding in most children with ASDs... Wakefield et al also proposed [and stated as not proven] a causal relation between measles, mumps, and rubella (MMR) vaccination and autism, a suggestion that was later retracted by many of the original authors." (14)

Now, why would the editor of a prominent journal like The Lancet reverse himself so completely?  The answer may have been presented in the aforementioned NYTimes article, where Horton mentions new vaccines about to enter the market.

"
I certainly hope that our retraction today will help to reassure parents that there really isn’t anything to be concerned about with the vaccine. I think there’s a history over many hundreds of years of anti-vaccine movements. We are going to see many, many more vaccines available to the general public, and we all have to be very vigilant about making sure that we build trust and confidence in these vaccines which are going to transform the landscape of health over the next generation." (18)

If data indicate an association between vaccinations and various autism-spectrum disorders, then new vaccines might be less well received. Should that happen, gross revenues and net profits for pharmaceutical companies that manufacture vaccines would be negatively impacted. Thus let us ask, is there evidence that MMR vaccinations may injure some children? According to peer-reviewed studies, the answer is Yes.

Part 3: The MMR and adverse events

NVICP: National Vaccine Injury Compensation Program (19)
VAERS: Vaccine Adverse Event Reporting System (20)
 
NVICP and VAERS exist because adverse effects associated with vaccinations have long been known. Although NVICP and VAERS recommend that even soft signals (reports of adverse reactions) merit concern, the emphasis for seeking soft signals is via professionals with credentials (20). In this schema, parental reports tend to remain virtually unheard. A major part of the heresy of Wakefield and his colleagues in 1998 is (a) they listened to parents who reported MMR-related regression into autism and MMR-related onset of bowel pathology, and (b) the researchers dared commit these parental observations into print in a prominent medical journal (1).

Circa 1997 and 1998 - give or take a few years - considering adverse effects from vaccinations was common and was enacted by researchers, by peer-reviewers, and by editors. For example, the NVICP's Robert E. Weibel, M.D. and colleagues had written a vaccination-effects study published in Pediatrics (23) one month after Wakefield et al 1998 was published in The Lancet (1; February 1998).

Weibel et al titled their study, "Acute Encephalopathy Followed by Permanent Brain Injury or Death Associated With Further Attenuated Measles Vaccines..." and concluded "...that a causal relationship between measles vaccine and encephalopathy may exist as a rare complication of measles immunization", whether from the measles vaccine, the measles-rubella vaccine, or the MMR (23).

Given that studies like Weibel et al 1998 were addressing legitimate concerns and were passing peer-review in prominent journals, Wakefield et al's speculation about possible links between the MMR and a regressive autism subgroup with gastrointestinal pathology was not as egregiously out-of-bounds as Richard Horton and major media would have us believe in 2010.

Part 4: a brief look at Weibel et al 1998

A. Published in March of 1998, the Weibel et al paper was in the pre-publication, peer-review process virtually the same time as was Wakefield et al 1998.

B. After major exclusions intended to eliminate co-factor influences, 48 severe adverse effects from MMR were identified amid NVCIP data.

C. The 48 cases of adverse effects were summarized as follows: "
Eight children died, and the remainder had mental regression and retardation, chronic seizures, motor and sensory deficits, and movement disorders." (23) Notice that Weibel et al's summary of findings is remarkably similar to traits described in PDD/NOS!

D. Subsequent reviews of MMR safety often interpret Weibel et al 1998 as showing how rare MMR adversities are.

E. Some MMR analyses cite Weibel et al 1998 as showing that adverse effects of MMR vaccinations are known and can be severe. Indeed, Weibel et al's MMR findings are consistent with more recent analyses, "Statistically significant increases in the incidence of serious neurologic disorders following pediatric MMR vaccine in comparison to DTwcP vaccine were found." (24) and "...there is biological plausibility and epidemiological evidence showing a direct relationship between... measles-containing vaccines and serious neurological disorders." (25)

F. The schedule of vaccinations for children in the U.S. and U.K. has increased dramatically since most years included the the Weibel et al analysis, and this increase has occurred in the absence of studies comparing adverse events in vaccinated and unvaccinated children.

G. Exclusions in Weibel et al 1998 are significant and suggest that the study's 48 severe MMR-related injuries may be the tip of a huge iceberg.

Part 5: Exclusions in Weibel et al 1998

The exclusion criteria used by Weibel and colleagues were important to their study's focus and to the researchers' ability to justify their conclusions. Nonetheless, the study's exclusions and several other factors suggest that Weibel et al's 48 severely injured children may represent a large under-estimation, as suggested by the data of Geier et al (24-25) and as reported by numerous parents including those in the study by Wakefield et al 1998 (1).

A. "Postinfectious encephalopathy complicates approximately 1 in 1000 cases of natural measles and results in a mortality rate of 10% to 20% and permanent central nervous system impairment in the majority of survivors... Case reports and reviews suggest that similar neurologic complications can, less frequently, follow the administration of live attenuated measles vaccine..." (23)

B. From 403 claims submitted to 48 cases included in the study:
        "A total of 403 claims of encephalopathy and/or seizure disorder after measles, MR, MMR, mumps, or rubella vaccination were identified during this 23-year period. Of these claims, 48 (25 males and 23 females) met the inclusion criteria and acquired an acute encephalopathy of undetermined cause 2 to 15 days after receiving measles vaccine, MR, or MMR." (23)

C. Underreporting:
        Weibel et al 1998: "The 48 cases of encephalopathy probably represent underreporting to this passive system, which does not require individuals to file for compensation and requires medical documentation." (23)  "
       FDA summary of reporting: "FDA receives by direct report less than 1% of suspected serious ADRs... This means that cases spontaneously reported to any surveillance program, which comprise the numerator, generally represent only a small portion of the number that have actually occurred." (20)

D. Vaccine Injury Table specifies: In the absence of an alternate cause [co-factors may cloud this issue, see below]
       "For an individual who received a measles, mumps, or rubella vaccine, the act grants, in the Vaccine Injury Table, the presumption of vaccine causation
if the first manifestation of encephalopathy occurs, in the absence of an alternate cause, 15 days or less after receiving any of these vaccines. The injury or its
residual effects, except when death occurs, must persist for >6 months." (23)

E. Exclusion by decree: changing eligibility time period from onset 15 days or less to onset between days 5 to 15, thus excluding MMR-induced deteriorations that began on days 1 thru 4 after the MMR vaccination. In Weibel et al (Figure 1, p 385) 6 of the 48 adverse events began prior to day 5.
       "Effective March 10, 1995, the [NVICP] program changed the time period of a Vaccine Table Injury for these vaccines and the onset of encephalopathy from <15 days to 5 to 15 days..." (23)

F. Abrupt onset included in Weibel et al, thus gradual onset excluded (23): Many parents have reported that their now autistic child's MMR-induced regression began soon after the MMR vaccination but was gradual and continued to develop (adversely) for months after the vaccination.

G. Exclusion of postictal: "Seizures with mental dysfunction attributed to the postictal state or medication were not considered to be encephalopathy." (23) Since chronic seizures were the most common adverse effect of measles, MR, and MMR vaccinations (23), to exclude postictal mental dysfunction seems to have eliminated from consideration neurologic deteriorations induced by seizures.

H. Infectious, toxic, metabolic exclusions: "Cases of encephalopathy were excluded if an infectious, toxic, traumatic, or metabolic cause or a recent exposure to natural measles, mumps, or rubella was identified or full recovery occurred within 6 months." (23)
       These three exclusions in Weibel et al 1998 have enhanced significance in 2010. Etiologically significant co-factors abound. Autism has long been associated with herpes simpex virus and with human herpesvirus 6 (eg, 26-27). Various airborne pollutants are associated with autism (28-30). Various gene alleles related to detoxification and metabolic processes are associated with autism (eg, 31-33). And classic mitochondrial disorders that are clinically silent prior to vaccinations (eg, Hannah Poling) or clinically more common mitochondrial dysfunction (34) also stand as risk factors which may be co-active along with MMR vaccinations - especially if the child's MMR vaccination occurs during the same incident in which a thimerosal-containing vaccine is injected (eg, 35-36). Enforcement of a one-size-fits-all vaccination schedule means that many children with known risk factors are being vaccinated, including with the MMR.

Conclusions: Citations and analysis presented in this brief essay make clear that The Lancet editor has waffled on behalf of future sales of current and new vaccines, that Wakefield et al's 1998 speculation about MMR vaccinations being linked with an autism subgroup were not far afield of other peer-reviewed studies, and - as various researchers have stated - increasing the safety of vaccinations merits ongoing attention. Adverse events happen and need continually be minimized.

Comments in a petition on behalf of physicians Wakefield, Murch, and Walker-Smith are informative (37).


References:

1.
Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children
Wakefield AJ et al.
Lancet. 1998 Feb 28;351(9103):637-41.

here

2. Richard Horton Waffles on Lancet's Wakefield Retraction
Sally Beck; Feb 12, 2010
http://www.huffingtonpost.com/sally-beck/richard-horton-waffles-on_b_460550.html

3.
Retracting a Medical Journal’s Autism Study
By TARA PARKER-POPE
http://well.blogs.nytimes.com/2010/02/08/did-the-media-inflame-the-vaccine-autism-link/

4.
Enterocolitis in children with developmental disorders
Wakefield AJ et al.
Am J Gastroenterol. 2000 Sep;95(9):2285-95.

5.
Colonic CD8 and gamma delta T-cell infiltration with epithelial damage in children with autism
Furlano RI et al.
J Pediatr. 2001 Mar;138(3):366-72.

6.
The significance of ileo-colonic lymphoid nodular hyperplasia in children with autistic spectrum disorder
Wakefield AJ et al.
Eur J Gastroenterol Hepatol. 2005 Aug;17(8):827-36.

7.
Immune activation of peripheral blood and mucosal CD3 lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms.
Ashwood P, Wakefield AJ.
J Neuroimmunol. 2006 Apr;173(1-2):126-34.

8.
Are there more bowel symptoms in children with autism compared to normal children and children with other developmental and neurological disorders?: A case control study
Smith RA et al.
Autism. 2009 Jul;13(4):343-55.

"There was a significant difference in the reporting of certain bowel symptoms (constipation, diarrhoea, flatulence) and food faddiness between the autism group and the mainstream school control group... It would appear, however, that this is not specifically associated with autism as bowel symptoms were reported in similar frequency to a comparison group of children with other developmental and neurological disorders."

9.
Autistic enterocolitis: Fact or fiction?
{excellent, brief overview}
P Galiatsatos, A Gologan, E Lamoureux
Can J Gastroenterol. 2009 Feb;23(2):95-8.
http://www.pulsus.com/journals/abstract.jsp?sCurrPg=journal&jnlKy=2&atlKy=8619&isuKy=837&isArt=t

10.
Clinical Presentation and Histologic Findings at Ileocolonoscopy in Children with Autistic Spectrum Disorder and Chronic Gastrointestinal Symptoms
Arthur Krigsman, Marvin Boris, Allan Goldblatt and Carol Stott
Autism Insights 2010:2 1-11; 27 Jan 2010
http://www.la-press.com/clinical-presentation-and-histologic-findings-at-ileocolonoscopy-in-ch-a1816

11.
Gastrointestinal Pathology in Autism Spectrum Disorders: The Venezuelan Experience
Lenny G. Gonzalez, MD
http://www.autismone.org/content/gastrointestinal-pathology-autism-spectrum-disorders-venezuelan-experience-lenny-g-gonzalez-


12.
On Second Looking into the Case of Dr. Andrew J. Wakefield
William Long, MDiv, PhD, JD
http://www.autismone.org/content/second-looking-case-dr-andrew-j-wakefield-william-long-mdiv-phd-jd

13.
Gastrointestinal pathologies in autism: Did Mayo's Ibrahim and colleagues err?
Teresa Binstock, Jan 31, 2010.
http://www.generationrescue.org/binstock/100131-autism-gastrointestinal-misleading-study.htm

14.
Evaluation, Diagnosis, and Treatment of Gastrointestinal Disorders in Individuals With ASDs: A Consensus Report
Buie T et al.
Pediatrics 2010;125:S1–S18.
http://pediatrics.aappublications.org/cgi/content/full/125/Supplement_1/S1

15.
Recommendations for Evaluation and Treatment of Common Gastrointestinal Problems in Children With ASDs
Buie T et al.
Pediatrics 2010;125:S19–S29
http://pediatrics.aappublications.org/cgi/content/full/125/Supplement_1/S19

16.
On Second Looking into the Case of Dr. Andrew J. Wakefield
William Long, MDiv, PhD, JD
http://www.autismone.org/content/second-looking-case-dr-andrew-j-wakefield-william-long-mdiv-phd-jd

17.
Gastrointestinal pathologies in autism: Did Mayo's Ibrahim and colleagues err?
Teresa Binstock, Jan 31, 2010.
http://www.generationrescue.org/binstock/100131-autism-gastrointestinal-misleading-study.htm

18.
Retracting a Medical Journal’s Autism Study
By TARA PARKER-POPE
http://well.blogs.nytimes.com/2010/02/08/did-the-media-inflame-the-vaccine-autism-link/

19.
NVICP
http://www.hrsa.gov/vaccinecompensation/default.htm

20.
The Clinical Impact of Adverse Event Reporting
FDA, 1996.
http://www.fda.gov/downloads/Safety/MedWatch/UCM168505.pdf

21.
Vaccine Adverse Event Reporting System (VAERS)
HHS
http://vaers.hhs.gov/index

22.
Post-marketing surveillance for adverse events after vaccination: the national Vaccine Adverse Event Reporting System (VAERS)
FDA, 1998.
http://www.fda.gov/downloads/Safety/MedWatch/UCM168497.pdf

23.
Acute Encephalopathy Followed by Permanent Brain Injury or Death Associated With Further Attenuated Measles Vaccines: A Review of Claims Submitted to the National Vaccine Injury Compensation Program
Received Jul 30, 1997; accepted Sep 23, 1997.
Robert E. Weibel*, Vito Caserta*, David E. Benor Dagger, and Geoffrey Evans*
>From the * Division of Vaccine Injury Compensation, National Vaccine Injury Compensation Program, Health Resources and Services Administration, Public Health Service, Rockville, Maryland; and the Dagger Office of the General Counsel, United States Department of Health and Human Services, Rockville, Maryland.
PEDIATRICS Vol. 101 No. 3 March 1998, pp. 383-387
http://pediatrics.aappublications.org/cgi/content/abstract/101/3/383
{some highlights added in abstract}

Objective.  To determine if there is evidence for a causal relationship between acute encephalopathy followed by permanent brain injury or death associated with the administration of
further attenuated measles vaccines (Attenuvax or Lirugen, Hoechst Marion Roussel, Kansas City, MO), mumps vaccine (Mumpsvax, Merck and Co, Inc, West Point, PA), or rubella vaccines (Meruvax or Meruvax II, Merck and Co, Inc, West Point, PA), combined measles and rubella vaccine (M-R-Vax or M-R-Vax II, Merck and Co, Inc, West Point, PA), or combined measles, mumps, and rubella vaccine (M-M-R or M-M-R II, Merck and Co, Inc, West Point, PA), the lead author reviewed claims submitted to the National Vaccine Injury Compensation Program.

Methods.  The medical records of children who met the inclusion criteria of receiving the first dose of these vaccines between 1970 and 1993 and who developed such an encephalopathy with no determined cause within 15 days were identified and analyzed.

Results.  A total of 48 children, ages 10 to 49 months, met the inclusion criteria after receiving measles vaccine, alone or in combination. Eight children died, and the remainder had mental regression and retardation, chronic seizures, motor and sensory deficits, and movement disorders. The onset of neurologic signs or symptoms occurred with a nonrandom, statistically significant distribution of cases on days 8 and 9. No cases were identified after the administration of monovalent mumps or rubella vaccine.

Conclusions. 
This clustering suggests that a causal relationship between measles vaccine and encephalopathy may exist as a rare complication of measles immunization.


24.
Pediatric MMR Vaccination Safety
Mark R. Geier, MD, PhD; David A Geier
International Pediatrics 2003;18(2):203-208.

Measles, mumps and rubella are viral infections that have the potential to result in globally destructive disorders. Measles, mumps and rubella (MMR) vaccine has helped to dramatically reduce the number of cases of measles, mumps and rubella infection, as well as to reduce the amount of pain and suffering associated with each of these natural infections. The purpose of this study was to analyze the incidence of serious neurologic disorders in a comparative examination between MMR vaccine and a vaccine control group. The Vaccine Adverse Events Reporting System (VAERS) database was analyzed for the incidence rate of permanent brain damage, cerebellar ataxia, autism and mental retardation reported following MMR vaccine and diphtheria, tetanus and whole-cell pertussis (DTwcP) containing-vaccines from 1994 through 2000 in the US.
Statistically significant increases in the incidence of serious neurologic disorders following pediatric MMR vaccine in comparison to DTwcP vaccine were found. The potentially globally destructive effects of natural measles, mumps and rubella infections means that continued vaccination is necessary, but improvements in MMR vaccines are needed to improve its safety.

25.
A comparative evaluation of the effects of MMR immunization and mercury doses from thimerosal-containing childhood vaccines on the population prevalence of autism.
Geier DA, Geier MR.
Med Sci Monit. 2004 Mar;10(3):PI33-9. Epub 2004 Mar 1.

BACKGROUND: The purpose of the study was to evaluate the effects of MMR immunization and mercury from thimerosal-containing childhood vaccines on the prevalence of autism. MATERIAL/METHODS: Evaluations of the Biological Surveillance Summaries of the Centers for Disease Control and Prevention (CDC), the U.S. Department of Education datasets, and the CDC's yearly live birth estimates were undertaken RESULTS: It was determined that there was a close correlation between mercury doses from thimerosal--containing childhood vaccines and the prevalence of autism from the late 1980s through the mid-1990s. In contrast, there was a potential correlation between the number of primary pediatric measles-containing vaccines administered and the prevalence of autism during the 1980s. In addition, it was found that there were statistically significant odds ratios for the development of autism following increasing doses of mercury from thimerosal-containing vaccines (birth cohorts: 1985 and 1990-1995) in comparison to a baseline measurement (birth cohort: 1984). The contribution of thimerosal from childhood vaccines (>50% effect) was greater than MMR vaccine on the prevalence of autism observed in this study. CONCLUSIONS: The results of this study agree with a number of previously published studies. These studies have shown that
there is biological plausibility and epidemiological evidence showing a direct relationship between increasing doses of mercury from thimerosal-containing vaccines and neurodevelopmental disorders, and measles-containing vaccines and serious neurological disorders. It is recommended that thimerosal be removed from all vaccines, and additional research be undertaken to produce a MMR vaccine with an improved safety profile.

26.
Acquired reversible autistic syndrome in acute encephalopathic illness in children
DeLong GR, Bean SC, Brown FR 3rd.
Arch Neurol. 1981 Mar;38(3):191-4.

27.
Serological association of measles virus and human herpesvirus-6 with brain autoantibodies in autism
Singh VK, Lin SX, Yang VC.
Clin Immunol Immunopathol. 1998 Oct;89(1):105-8.

28.
Autism spectrum disorders in relation to distribution of hazardous air pollutants in the san francisco bay area
Windham GC, Zhang L, Gunier R, Croen LA, Grether JK.
Environ Health Perspect. 2006 Sep;114(9):1438-44.

29.
Maternal residence near agricultural pesticide applications and autism spectrum disorders among children in the California Central Valley
Roberts EM, English PB, Grether JK, Windham GC, Somberg L, Wolff C.
Environ Health Perspect. 2007 Oct;115(10):1482-9.

30.
Proximity to point sources of environmental mercury release as a predictor of autism prevalence.
Palmer RF, Blanchard S, Wood R.
Health Place. 2009 Mar;15(1):18-24.

31.
Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism.
James SJ ete al.
Am J Med Genet B Neuropsychiatr Genet. 2006 Dec 5;141B(8):947-56.

32.
One Carbon Metabolism Disturbances and the C667T MTHFR Gene Polymorphism in Children with Autism Spectrum Disorders.
Paşca SP et al.
J Cell Mol Med. 2008 Aug 9. [Epub ahead of print]

33.
Paraoxonase gene variants are associated with autism in North America, but not in Italy: possible regional specificity in gene-environment interactions
D'Amelio M et al.
Mol Psychiatry. 2005 Nov;10(11):1006-16.

34.
Evidence of Mitochondrial Dysfunction in Autism and Implications for Treatment
Daniel A. Rossignol, J. Jeffrey Bradstreet
American Journal of Biochemistry and Biotechnology 4 (2): 208-217, 2008
{free online}
http://www.scipub.org/fulltext/ajbb/ajbb42208-217.pdf

35.
Hepatitis B triple series vaccine and developmental disability in US children aged 1-9 years
 Gallagher C, Goodman M. Toxicol Environ Chem 2008 90(5):997-1008.
{free online}
http://fourteenstudies.org/pdf/hep_b.pdf

"The odds of receiving EIS were approximately nine times as great for vaccinated boys... as for unvaccinated boys..., after adjustment for confounders.

36.
Hepatitis B vaccination of male neonates and autism
[conference abstract as published]
CM Gallagher, MS Goodman, Graduate Program in Public
Health, Stony Brook University Medical Center, Stony Brook, NY
Annals of Epidemiology, p659
Vol. 19, No. 9 Abstracts (ACE) September 2009: 651–680

[triple the rate of autism among boys vaccinated with thimerosal versus boys not so vaccinated]

37. Petition on behalf of Wakefield, Murch, and Walker-Smith

Contact Teresa Binstock by email


Return to index of essays by Teresa Binstock